80 related articles for article (PubMed ID: 3034748)
1. Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia.
Petraglia F; Golinelli S; d'Ambrogio G; Comitini G; Facchinetti F; Volpe A; Genazzani AR
Gynecol Obstet Invest; 1987; 23(2):117-21. PubMed ID: 3034748
[TBL] [Abstract][Full Text] [Related]
2. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
Van Vugt DA; Lam NY; Ferin M
Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
[TBL] [Abstract][Full Text] [Related]
3. The role of endogenous opiates in LH secretion during the menstrual cycle.
Quigley ME; Yen SS
J Clin Endocrinol Metab; 1980 Jul; 51(1):179-81. PubMed ID: 7380991
[TBL] [Abstract][Full Text] [Related]
4. Endorphins and the regulations of the human menstrual cycle.
Blankstein J; Reyes FI; Winter JS; Faiman C
Clin Endocrinol (Oxf); 1981 Mar; 14(3):287-94. PubMed ID: 6790206
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opiates modulate pulsatile luteinizing hormone release in humans.
Ropert JF; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1981 Mar; 52(3):583-5. PubMed ID: 6780598
[TBL] [Abstract][Full Text] [Related]
8. Sleep-associated decrease in luteinizing hormone pulse frequency during the early follicular phase of the menstrual cycle: evidence for an opioidergic mechanism.
Rossmanith WG; Yen SS
J Clin Endocrinol Metab; 1987 Oct; 65(4):715-8. PubMed ID: 2821052
[TBL] [Abstract][Full Text] [Related]
9. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
10. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
[TBL] [Abstract][Full Text] [Related]
11. Transient failure of central opioid tonus and premenstrual symptoms.
Facchinetti F; Martignoni E; Sola D; Petraglia F; Nappi G; Genazzani AR
J Reprod Med; 1988 Jul; 33(7):633-8. PubMed ID: 3050071
[TBL] [Abstract][Full Text] [Related]
12. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
[TBL] [Abstract][Full Text] [Related]
14. Opioid control of luteinizing hormone secretion in humans.
Genazzani AR; Petraglia F
J Steroid Biochem; 1989 Oct; 33(4B):751-5. PubMed ID: 2689783
[TBL] [Abstract][Full Text] [Related]
15. Influence of opioids on LH secretion in gilts during the estrous cycle.
Okrasa S; Kalamarz H; Tilton JE; Ziecik AJ
J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):105-16. PubMed ID: 1343963
[TBL] [Abstract][Full Text] [Related]
16. Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion.
Limonta P; Dondi D; Maggi R; Martini L; Piva F
Endocrinology; 1989 Feb; 124(2):681-6. PubMed ID: 2912695
[TBL] [Abstract][Full Text] [Related]
17. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
18. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
Ebling FJ; Schwartz ML; Foster DL
Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
[TBL] [Abstract][Full Text] [Related]
19. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy.
Petraglia F; Larizza D; Maghnie M; Facchinetti F; Volpe A; Bernasconi S; Genazzani AR; Severi F
J Clin Endocrinol Metab; 1988 May; 66(5):1024-8. PubMed ID: 3129445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
